We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$7.72B
1-Year Est. Return
32.88%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+32.88%
3 Year Est. Return
+87.32%
5 Year Est. Return
+53.71%
10 Year Est. Return
–
AUM
$558M
AUM Growth
+$80.9M
(+17%)
Cap. Flow
+$74.8M
Cap. Flow
% of AUM
13.4%
Top 10 Holdings %
Top 10 Hldgs %
4.09%
Holding
1,998
New
777
Increased
301
Reduced
272
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$3.2M |
| 2 |
Boeing
BA
|
+$2.64M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.42M |
| 4 |
Amgen
AMGN
|
+$2.03M |
| 5 |
Elevance Health
ELV
|
+$1.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.64M |
| 2 |
Lockheed Martin
LMT
|
+$2.31M |
| 3 |
Cigna
CI
|
+$2.21M |
| 4 |
Wells Fargo
WFC
|
+$2.18M |
| 5 |
Paychex
PAYX
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Healthcare | 15.66% |
| 3 | Consumer Discretionary | 14.41% |
| 4 | Industrials | 14.14% |
| 5 | Financials | 12.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Tredegar Corp
TG
$240M
| $72.2K | 0.01% |
+10,818
| New | +$85.8K |
|
1202
Alector
ALEC
$213M
| $70.5K | 0.01% |
+11,727
| New | +$81.9K |
|
|
PFSW
1203
DELISTED
PFSweb, Inc.
PFSW
| $70.3K | 0.01% |
15,542
-2,266
| -13% | -$9.45K |
|
1204
Marqeta
MQ
$1.62B
| $70K | 0.01% |
3,594
-14,565
| -80% | -$264K |
|
1205
Design Therapeutics
DSGN
$766M
| $68K | 0.01% |
+10,799
| New | +$66.1K |
|
1206
1stdibs.com
DIBS
$136M
| $67.2K | 0.01% |
+17,964
| New | +$68.4K |
|
1207
DarioHealth
DRIO
$70.6M
| $67K | 0.01% |
+836
| New | +$63.5K |
|
1208
First Majestic Silver
AG
$9.78B
| $67K | 0.01% |
11,852
-29,779
| -72% | -$191K |
|
1209
Rigetti Computing
RGTI
$5.26B
| $66.8K | 0.01% |
+56,832
| New | +$42.6K |
|
1210
Caribou Biosciences
CRBU
$139M
| $66.1K | 0.01% |
15,553
+209
| +1% | +$939 |
|
|
EMAN
1211
DELISTED
eMagin Corporation
EMAN
| $66K | 0.01% |
+33,353
| New | +$65.7K |
|
1212
ESS Tech
GWH
$14.5M
| $65.2K | 0.01% |
+2,959
| New | +$53.5K |
|
|
HYPD
1213
Hyperion DeFi Inc
HYPD
$60.9M
| $64.9K | 0.01% |
+343
| New | +$98.3K |
|
|
TCS
1214
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $64K | 0.01% |
1,359
+608
| +81% | +$27K |
|
1215
IAMGOLD
IAG
$11.6B
| $62.7K | 0.01% |
23,830
-80,286
| -77% | -$232K |
|
1216
BlackRock Enhanced International Dividend Trust
BGY
$524M
| $61.8K | 0.01% |
11,357
+132
| +1% | +$723 |
|
|
TRML
1217
DELISTED
Tourmaline Bio
TRML
| $60.4K | 0.01% |
+1,988
| New | +$50.8K |
|
1218
Nuvation Bio
NUVB
$2.05B
| $60.4K | 0.01% |
33,553
-16,021
| -32% | -$27.2K |
|
1219
Scilex Holding
SCLX
$35.5M
| $60.1K | 0.01% |
+308
| New | +$85K |
|
1220
Sana Biotechnology
SANA
$928M
| $60.1K | 0.01% |
10,081
-3,137
| -24% | -$18.1K |
|
1221
Wipro
WIT
$16.4B
| $59.5K | 0.01% |
25,216
-46,976
| -65% | -$109K |
|
1222
Lantronix
LTRX
$273M
| $58.3K | 0.01% |
+13,853
| New | +$59K |
|
1223
Gold Royalty Corp
GROY
$774M
| $58K | 0.01% |
+32,765
| New | +$67.8K |
|
1224
BioVie
BIVI
$13.7M
| $57.7K | 0.01% |
+134
| New | +$90.3K |
|
1225
Apyx Medical
APYX
$129M
| $57.7K | 0.01% |
+11,469
| New | +$58.1K |
|
Similar funds
AL
EGM
CGH
CG
NAMA
AAB
AC
EMPI
XTX Topco's Q2 2023 Portfolio in Review
As of Q2 2023, XTX Topco held 1,998 positions worth $558M, up 17% from $477M the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.
XTX Topco deployed $74.8M of net new capital in Q2 2023, opening 777 new positions and adding to 301 existing holdings. Its largest new stake was Target: 21,561 shares worth $2.84M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lockheed Martin, an estimated $2.31M trimmed.
- XTX Topco's largest Q2 2023 buy was Target: 21,561 shares worth $2.84M.
- XTX Topco added most to Alphabet (Google) Class A in Q2 2023, an estimated $2.42M increase.
- XTX Topco's biggest Q2 2023 reduction was Lockheed Martin, cutting an estimated $2.31M.
- XTX Topco fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $2.64M.
- XTX Topco's ten largest holdings make up 4.1% of its $558M portfolio in Q2 2023.
- XTX Topco opened 777 new positions and closed 643 in Q2 2023.
- XTX Topco's portfolio value rose 17% quarter-over-quarter to $558M.
Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.